Karen A Veverka

1PUBLICATIONS
2CO-AUTHORS
Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 15, 2024
Eblasakimab, an Anti-IL‑13Rα1 Antibody, Reduces Atopy-Associated Serum Biomarkers in Moderate‑to‑Severe Atopic Dermatitis.

Ferda Cevikbas, Alison Ward, Karen A Veverka

Pageof 1